Q2 2024 Adjusted EBITDA 7% above Q2 2023; Improvement in gross margin and adjusted EBITDA margin in Q2 & H1 2024 following strict inventory management allowing the Company to benefit from market costs, positive product sales mix and continued OPEX management measures;
Significant improvement in cash flow despite challenging market conditions; Positive operating cash flow of $243 million achieved in H1 2024 in comparison to a negative cash flow of $19 million in H1 2023; Positive free cash flow of $51m achieved in H1 2024 in comparison to a negative cash flow of $254m in H1 2023;
Implementation of transformation plan underway, showing initial benefits as challenging market conditions continue.
Second Quarter 2024 Highlights:
Sales down 16% to $1,041 million (-14% in RMB terms; -14% in CER[1] terms), mainly reflecting a 10% decrease in prices and a 4% decrease in volumes
Gross profit amounted to $269m (margin of 25.8%) vs $277m (margin of 22.5%) in Q2 2023
Adjusted EBITDA amounted to $120 million (margin of 11.5%) vs. $112 million (margin of 9.1%) in Q2 2023
Adjusted net loss of $61 million; Reported net loss of $94 million
Operating cash flow of $347million in Q2 2024 vs $405 million in Q2 2023
Free cash flow of $245 million in Q2 2024 vs $288 million in Q2 2023
First Half Year 2024 Highlights:
Sales down 16% to $2,098 million (-14% in RMB terms; -14% in CER terms), mainly reflecting a 10% decrease in prices and a 4% decrease in volumes
Gross profit amounted to $557m (margin of 26.5%) vs $617m (margin of 24.8%) in H1 2023
Adjusted EBITDA amounted to $252 million (margin of 12.0%) vs. $277 million (margin of 11.1%) in H1 2023
Adjusted net loss of $71 million; Reported net loss of $126 million
Improvement of $262 million in operating cash flow; $243 million in H1 2024 vs -$19 million in H1 2023
Improvement of $305 million in free cash flow; $51 million in H1 2024 vs -$254 million in H1 2023
BEIJING and TEL AVIV, Israel, Aug. 28, 2024 /PRNewswire/ -- ADAMA Ltd. (the "Company") (SZSE: 000553), today reported its financial results for the second quarter and first half of 2024 that ended June 30, 2024.
Steve Hawkins, President and CEO of ADAMA, said, "While the crop protection market remains challenging, we are focused on our transformation plan aimed at improving the quality of our business and strengthening our position in the fast-growing Value Innovation customer segment. We continue to launch a wide array of advanced, differentiated products with strong ROI for farmers in our largest and most important markets. The agriculture industry is cyclical in nature and ADAMA is taking the necessary steps to maximize our ability to capture opportunities when the market turns around. We believe that our value innovation portfolio is exactly the right fit for the large segment of growers who are looking for innovation but will be pressured by declining commodity prices and seeking cost effective solutions.
"Our transformation plan is already showing initial positive results with higher EBITDA achieved in the second quarter, as well as an improvement in the gross and EBITDA margins in both the second quarter and the first half of 2024. This improvement was driven by efficient inventory management, better product sales mix as well as a steady reduction in operating expenses. Steps taken in working capital and CAPEX management have brought a significant improvement in cashflow in the first half of 2024.
"We are still in the first phase of our transformation in ADAMA and as the market eventually turns around, we expect to see significant acceleration of the plan's impact on our financial results."
Table 1. Financial Performance Summary
USD (m)
As Reported
Adjustments
Adjusted
Q2
2024
Q2
2023
% Change
Q2
2024
Q2
2023
Q2
2024
Q2
2023
% Change
Revenues
1,041
1,233
(16 %)
-
-
1,041
1,233
(16 %)
Gross profit
227
253
(10 %)
41
24
269
277
(3 %)
% of sales
21.8 %
20.6 %
25.8 %
22.5 %
Operating income (EBIT)
(16)
40
69
6
52
46
13 %
% of sales
(1.6 %)
3.3 %
5.0 %
3.8 %
Loss before taxes
(59)
(56)
6 %
42
6
(17)
(50)
(65 %)
% of sales
(5.7 %)
(4.5 %)
(1.7 %)
(4.0 %)
Net loss
(94)
(46)
102 %
33
5
(61)
(41)
48 %
% of sales
(9.0 %)
(3.8 %)
(5.8 %)
(3.3 %)
EPS
- USD
(0.0403)
(0.0199)
(0.0261)
(0.0177)
- RMB
(0.2864)
(0.1397)
(0.1855)
(0.1238)
EBITDA
76
115
(34 %)
44
(3)
120
112
7 %
% of sales
7.3 %
9.3 %
11.5 %
9.1 %
USD (m)
As Reported
Adjustments
Adjusted
H1
2024
H1
2023
% Change
H1
2024
H1
2023
H1
2024
H1
2023
% Change
Revenues
2,098
2,492
(16 %)
-
-
2,098
2,492
(16 %)
Gross profit
484
563
(14 %)
73
54
557
617
(10 %)
% of sales
23.0 %
22.6 %
26.5 %
24.8 %
Operating income (EBIT)
34
132
(74 %)
89
16
124
148
(16 %)
% of sales
1.6 %
5.3 %
5.9 %
5.9 %
Loss before taxes
(80)
(45)
78 %
65
16
(16)
(29)
% of sales
(3.8 %)
(1.8 %)
(0.7 %)
(1.2 %)
Net loss
(126)
(34)
268 %
55
15
(71)
(20)
% of sales
(6 %)
(1.4 %)
(3.4 %)
(0.8 %)
EPS
- USD
(0.0541)
(0.0147)
(0.0303)
(0.0084)
- RMB
(0.3841)
(0.1039)
(0.2152)
(0.0604)
EBITDA
196
281
(30 %)
55
(4)
252
277
(9 %)
% of sales
9.4 %
11.3 %
12.0 %
11.1 %
Notes:
"As Reported" denotes the Company's financial statements according to the Accounting Standards for Business Enterprises and the implementation guidance, interpretations and other relevant provisions issued or revised subsequently by the Chinese Ministry of Finance (the "MoF) (collectively referred to as "ASBE"). Note that in the reported financial statements, according to the ASBE guidelines [IAS 37], certain items (specifically certain transportation costs and certain idleness charges) are classified under COGS. Please see the appendix to this release for further information.
Relevant income statement items contained in this release are also presented on an "Adjusted" basis, which exclude items that are of a transitory or non-cash/non-operational nature that do not impact the ongoing performance of the business, and reflect the way the Company's management and the Board of Directors view the performance of the Company internally. The Company believes that excluding the effects of these items from its operating results allows management and investors to effectively compare the true underlying financial performance of its business from period to period and against its global peers. A detailed summary of these adjustments appears in the appendix below.
The number of shares used to calculate both basic and diluted earnings per share in both Q2 and H1 2024 and 2023 is 2,329.8 million shares.
In this table and all tables in this release numbers may not sum due to rounding.
The General Crop Protection (CP) Market Environment[2]
Key commodity crop prices continued to decline through the second quarter of 2024, although remain above average historical levels. Farmer income is pressured by the declining crop commodity prices, however, there has been some ease in the prices of inputs such as fertilizers.
The channel inventory situation continues to ease but the high interest rate environment coupled with ample product supply continue to drive a just-in-time purchasing approach by the channel. Active ingredient prices from China remained low during Q2 with some molecules even experiencing further price declines. Container shipping costs climbed higher during Q2 due to the combination of the red sea disruptions coupled with higher global trade demand.
Update on the War Situation in Israel
ADAMA is headquartered in Israel and has three manufacturing sites in the country. Following October 7th, 2023, the Company continued the production in its global manufacturing sites and in Israel, with certain non-significant restrictions (which have been lifted in February 2024). This situation did not have a material impact on the Company's ability to support its markets or on ADAMA's consolidated financial results.
On the 14th of April, Israel was under an attack from Iran, with no consequences to the Company's ongoing activities.
Update on Impact of Shipping Obstructions
In January 2024 some major shipping lines announced that they will suspend shipping to Israel through Israeli ports and through the Suez Canal due to tensions in the Red Sea. This has led to longer transportation times, with shipping lines being diverted around Africa.
As of the date of publication of this report, shipping time and costs have increased significantly, mainly in the China-Israel/Europe; China-America routes in comparison to before January 2024. Currently, the Company does not anticipate this to have a significant impact on its financial results or on the ongoing supply of materials to its production facilities, due to the Company's strict inventory management, although this situation might impact the company's ability to respond quickly to changing market demand.
"Fight Forward" Transformation Plan
As announced in the ADAMA's full year 2023 financial results report, it initiated a plan in the first quarter of 2024 to revalue ADAMA through improving the quality of the business to turnaround the Company. The Company-wide transformation plan is aimed at gradually delivering profit and cash targets over a period of 3 years (2024-2026).
Portfolio Development Update
Product Launches, Registrations:
During the second quarter of 2024 ADAMA continued to register and launch multiple new products in markets across the globe, adding on to its differentiated product portfolio.
Differentiated products address specific grower needs through innovative formulation technology and/or novel mixing concepts of Active Ingredients.
Select launches of differentiated products during the second quarter of 2024 include:
Launch of Prothioconazole based products, part of ADAMA's comprehensive portfolio of innovative solutions for cereal fungicides- Protadis® and Magan® in Turkey, powered by ADAMA's proprietary Asorbital® Formulation Technology- - Maxentis® in Australia
Vinergy® in Italy and France – a unique combination of folpet, a protectant fungicide with multi-site contact activity and potassium phosphonate, a systemic fungicide rapidly distributed in the whole plant. The combination of both active ingredients ensures long lasting plant protection against downy mildew.
Selected registrations of differentiated products during the second quarter of 2024 include:
Registration of Prothioconazole based products, part of ADAMA's comprehensive portfolio of innovative solutions for cereal fungicides in Europe, including:- Soratel® in Spain, Hungary, Moldova, Slovenia and Slovakia & Morocco powered by ADAMA's proprietary Asorbital® Formulation Technology- Avastel® in France, Poland and Latvia, powered by ADAMA's proprietary Asorbital® Formulation Technology- Maganic® in Italy and Slovakia, powered by ADAMA's proprietary Asorbital® Formulation Technology- Forapro® in Slovakia and Lithuania, powered by ADAMA's proprietary Asorbital® Formulation Technology- Maxentis® in Spain, Italy, Hungary, Romania and Greece & Moldova, a dual mode broad spectrum fungicide
Registration of Edaptis® in Poland. EDAPTIS® is a ready-to-use solution that provides broad-spectrum control of grassy weeds and improved efficacy in combating resistant populations.
Registration of Bazak® in India. BAZAK® is a new strong solution helping farmers controlling brown plant hoppers in rice thanks to the combination of 2 systemic molecules (Pymetrozine and Dinotefuran) having different mode of actions.
Registration of Forpido® in India - FORPIDO® is an innovative insecticide combining Chlorantraniliprole, Fipronil and Zinc that controls resistant rice stem borer and improves early crop establishment.
Folpet & Captan active ingredient renewal in Europe, supporting the ongoing marketing of Folpan® 500SC, Folpan® 800WG and Merpan® 800WG
Select patent granted during the second quarter of 2024 includes:
Patent granted for Sesgama® in EU, a proprietary formulation technology platform for high-load and other challenging formulations, enabling less use of co-formulants, transport and packaging materials per acre treated with a resulting improved product sustainability profile. First products expected to be launched in the coming years in EU.
Patent of Upturn® in India
Patent of Forabaz® in India
Financial Highlights
Revenues in the second quarter declined by approximately 16% (-14% in RMB terms; -14% in CER terms) to $1,041 million, presenting a decrease of 10% in prices and a decrease of 4% in volumes. The lower sales reflect lower market prices and de-focus from selected low profit products. Inventory levels in some areas have improved, however, high competition from Chinese and Indians manufactures increased pricing pressure mainly in commoditized crop protection products, while the channel is exercising more cautious buying patterns in light of previous price volatility and a higher interest rate environment.
These results brought the revenues in the first half of 2024 to $2,098 million, a decline of approximately 16% (-14% in RMB terms; -14% in CER terms), reflecting a decrease of 10% in prices and a decrease of 4% in volumes.
Table 2. Regional Sales Performance
Q2 2024
$m
Q2 2023
$m
Change
USD
Change
CER
H1 2024
$m
H1 2023
$m
Change
USD
Change
CER
Europe, Africa & Middle East
312
334
(7 %)
(6 %)
679
765
(11 %)
(8 %)
North America
223
225
(1 %)
(1 %)
414
436
(5 %)
(5 %)
Latin America
209
329
(37 %)
(33 %)
400
562
(29 %)
(28 %)
Asia Pacific
298
345
(14 %)
(12 %)
605
729
(17 %)
(15 %)
Of which China
121
141
(14 %)
(12 %)
275
323
(15 %)
(13 %)
Total
1,041
1,233
(16 %)
(14 %)
2,098
2,492
(16 %)
(14 %)
Notes:
CER: Constant Exchange RatesNumbers may not sum due to rounding
Europe, Africa & Middle East (EAME):
Sales in EAME decreased in the second quarter and first half of 2024, despite demand recovering in Europe at the farmer level in the second quarter supported by positive weather in Western and Southern Europe, slowly improving inventory levels. Overall pricing was softer, particularly in commoditized products, with new competition coming into the market.
North America: Consumer & Professional Solutions – Sales were higher in the second quarter following normalized buying patterns supported by good weather, while the Company focused on higher margin products. In the half year period sales were stable.
In the US Ag market, sales declined in the second quarter and first half of 2024 reflecting overall good weather, with the season progressing as usual, while new competition from China and India is putting pressure on pricing. Channel inventory levels have declined with purchasing patterns on a just-in-time basis. Pricing is currently stabilizing, although still lower than during H1 2023.
ADAMA's sales in Canada declined in the second quarter and first half of 2024 reflecting low insecticide sales as weather conditions were unfavorable for insect pressure. While inventory levels are declining, mainly in herbicide and fungicides, purchasing patterns on a just-in-time basis. Additionally, the market experienced strong competition and softer pricing particularly in commoditized products.
Latin America: Brazil – decline in sales in the second quarter and first half of 2024, reflecting the softer pricing, competition from Chinese competitors, "wait and see" famers behavior postponing CP purchases, as well as de-focus from non-selective herbicides. Channel inventory has mostly normalized however demand is impacted by expectations for additional price decreases. The Company is focusing its sales on higher margin products, with new product introductions of differentiated products continuing to do well.
In the rest of LATAM lower sales reflected the overall contraction in the market in Northern LATAM negatively impacted by El Niño weather. Inventory levels are back to normal levels in most countries, while pricing was impacted by high competition, mostly in commoditized products.
Asia-Pacific (APAC):
In China, the branded formulations sales in the second quarter and first half of 2024 were impacted by pressure on pricing and negative weather in southern China while focusing on improving the quality of the business with differentiated products. High channel inventories especially for cash crops. In the non-ag business, market pricing in has normalized while tech sales were mainly impacted by a "wait and see" approach in the market.
In the Pacific region, sales declined impacted by softer pricing following competition from China and India. Despite this, better weather conditions than expected brought an increase in demand, mainly in Pacific countries in the second quarter of 2024. While channel inventories have declined, purchasing patterns are on a just-in-time basis.
Sales in India were impacted by overall negative season with erratic weather and low pest pressure and softer pricing, particularly in commoditized products. Channel inventories have increased due to the weak season.
Sales in the wider APAC region continued to experience pricing pressure following intense competition from China, particularly in commoditized products, while good weather conditions supported demand.
Gross Profit reported in the second quarter reached $227 million (gross margin of 21.8%) compared to $253 million (gross margin of 20.6%) in the same quarter last year, and reached $484 million (gross margin of 23.0%) in the half year period compared to $563 million (gross margin of 22.6%) last year.
Adjustments to reported results: The adjusted gross profit mainly includes reclassification of all inventory impairment, taxes and surcharge and excludes certain transportation costs (classified under operating expenses), as well as a provision related to the soil cleanup and remediation regarding the Company's plant in Be'er Sheva.
Adjusted gross profit in the second quarter reached $269 million (gross margin of 25.8%) compared to $277 million (gross margin of 22.5%) in the same quarter last year, and reached $557 million (gross margin of 26.5%) in the half year period compared to $617 million (gross margin of 24.8%) last year.
Despite the decline in sales in the second quarter and first half of 2024, the Company improved the gross margin following the positive impact of new inventory sold, priced at market levels and following management's focus on the quality of business which led to an improvement in the sales mix of higher margin products. In the second quarter and first half of 2024, exchange rates had a negative impact.
Operating expenses reported in the second quarter of 2024 were $244 million (23.4% of sales), compared to $213 million (17.3% of sales) in the same quarter last year and reached $449 million (21.4% of sales) in the half year period compared to $431 million (17.3% of sales) last year.
Adjustments to reported results: please refer to the explanation regarding adjustments to the gross profit in respect to certain transportation costs, taxes and surcharges and inventory impairment.
Additionally, the Company recorded certain non-operational items within its reported operating expenses amounting to $56 million in Q2 2024 in comparison to $6 million in Q2 2023 and $76 in H1 2024 in comparison to $15 in H1 2023. These include mainly (i) provisions, such as legal claims, registration impairment and update of registration depreciation (ii) measures to improve efficiencies, (iii) non-cash amortization charges in respect of Transfer Assets received from Syngenta related to the 2017 ChemChina-Syngenta acquisition, (iv) charges related to the non-cash amortization of intangible assets created as part of the Purchase Price Allocation (PPA) on acquisitions, with no impact on the ongoing performance of the companies acquired. For further details on these non-operational items, please see the appendix to this release.
Adjusted operating expenses in the second quarter were $216 million (20.8% of sales), compared to $231 million (18.7% of sales) in the same quarter last year, and reached $433 million (20.6% of sales) in the half year period compared to $469 million (18.8% of sales) last year.
The operating expenses were lower in the second quarter and first half of 2024, following undertaking tight OPEX management measures, including the impact of initiatives included in the Company's transformation plan, lower transportation and logistics costs and the positive impact of exchange rates.
Operating income reported in the second quarter amounted to a loss of $16 million)-1.6% of sales) compared to an income of $40 million (3.3% of sales) in the second quarter of 2023 and amounted to $34 million (1.6% of sales) in the half year period compared to $132 million (5.3% of sales) last year.
